<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03685968</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-13-0024</org_study_id>
    <nct_id>NCT03685968</nct_id>
  </id_info>
  <brief_title>King Vision® and GlideScope® in Difficult Airways</brief_title>
  <official_title>A Comparison of the King Vision® Channeled, King Vision® Non-Channeled, and Glidescope® Video Intubation Systems in Patients at Risk for Difficult Intubation - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Systems Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are several advantages of video laryngoscopy; especially their ability to provide
      superior glottis visualization, as compared to traditional laryngoscopy.1-3 The purpose of
      this three arm study was to compare the safety and efficacy of the King Vision® Video
      Intubation Systems (AMBU-King Systems, Denmark) to the Cobalt GlideScope® (Verathon Medical
      Inc., USA) in patients with anticipated difficult airways.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 6, 2013</start_date>
  <completion_date type="Actual">December 17, 2015</completion_date>
  <primary_completion_date type="Actual">November 17, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Successful Tracheal Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL</measure>
    <time_frame>During laryngoscopy and endotracheal tube placement</time_frame>
    <description>The overall intubation success rates for all 3 video laryngoscopes - GSAVL, KVChVL and KVNChVL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First-attempt Successful Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL</measure>
    <time_frame>During laryngoscopy and endotracheal tube placement</time_frame>
    <description>The overall first-attempt success rates for all 3 video laryngoscopes - GSAVL, KVChVL and KVNChVL</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Final Intubation Time for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL</measure>
    <time_frame>During laryngoscopy and endotracheal tube placement</time_frame>
    <description>Total time for placing the endotracheal tube (ETT) through the vocal cords</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">225</enrollment>
  <condition>Airway Management</condition>
  <arm_group>
    <arm_group_label>Glidescope AVL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>King Vision Channeled VL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>King Vision Non-Channeled (Standard) VL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Video laryngoscopes</intervention_name>
    <description>Patients were randomized into one of the three groups through a computer generated randomization schedule. Patients in group A (N= 75) will be intubated using the GlideScope® AVL, patients in group B (N= 75) will be intubated using the King Vision Channeled VL; patients in group C (N=75) will be intubated using the King Vision Video Laryngoscope with Standard (non-channeled) Blade. Patients will only be tested with one device. All patients will be intubated using a conventional ETT.</description>
    <arm_group_label>Glidescope AVL</arm_group_label>
    <arm_group_label>King Vision Channeled VL</arm_group_label>
    <arm_group_label>King Vision Non-Channeled (Standard) VL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years of age

          -  Mallampati III-IV

          -  Neck circumference &gt; 43cm

          -  Reduced mouth opening (&lt; 4cm) or 3 Finger breath's (patient's own)

          -  Thyromental distance &lt; 6cm

        Exclusion Criteria:

          -  Mallampati I-II

          -  Neck circumference &lt; 43cm

          -  Documented 'easy' intubation

          -  Previous history of failed intubation and failed bag-mask ventilation

          -  Under 18 years of age

          -  ASA IV

          -  Known unstable cervical spine injury

          -  Presentation for an emergency surgical procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carin A Hagberg, MD</last_name>
    <role>Study Chair</role>
    <affiliation>The University of Texas MD Anderson Cancer Center</affiliation>
  </overall_official>
  <reference>
    <citation>Hagberg CA, Iannucci D, Goodrich A. A comparison of the glottic view obtained with the Macintosh Video Laryngoscope in anesthetized, paralyzed, apneic patients. Direct view vs video monitor. Anesthesiology 2003; 103: A1501.</citation>
  </reference>
  <reference>
    <citation>Hagberg C, Matuszczak M, Ellis S, et al. A randomized comparison of laryngoscopy techniques using the video laryngoscope and the traditional Macintosh laryngoscope in obese patients. Anesthesiology 2005; 103: A1420.</citation>
  </reference>
  <reference>
    <citation>Hagberg C, Vogt-Harenkamp C, Bogomolny Y, et al. A comparison of laryngoscopy techniques using the video laryngoscope and the traditional Macintosh laryngoscope in potentially difficult to intubate patients. Anesth Analg 2005; 100: S-212.</citation>
  </reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>September 24, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <results_first_submitted>November 7, 2018</results_first_submitted>
  <results_first_submitted_qc>December 10, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">January 4, 2019</results_first_posted>
  <last_update_submitted>January 4, 2019</last_update_submitted>
  <last_update_submitted_qc>January 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>M.D. Anderson Cancer Center</investigator_affiliation>
    <investigator_full_name>Carin A. Hagberg</investigator_full_name>
    <investigator_title>Chief Academic Officer and Division Head of Anesthesiology, Critical Care, and Pain Medicine</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were enrolled from the adult surgical operating rooms of 2 academic hospitals, Lyndon Baines Johnson General Hospital and Memorial Hermann Hospital — Texas Medical Center, in Houston, TX from August 2013 to December 2015.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Glidescope AVL</title>
          <description>Group A: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group A (N= 75) were intubated utilizing the GlideScope® AVL.</description>
        </group>
        <group group_id="P2">
          <title>King Vision Channeled VL</title>
          <description>Group B: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group B (N= 75) were intubated utilizing the King Vision Channeled VL.</description>
        </group>
        <group group_id="P3">
          <title>King Vision Non-Channeled (Standard) VL</title>
          <description>Group C: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group C (N=75) were intubated utilizing the King Vision Video Laryngoscope with Standard (Non-Channeled) Blade.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Glidescope AVL</title>
          <description>Group A: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group A (N= 75) were intubated utilizing the GlideScope® AVL.</description>
        </group>
        <group group_id="B2">
          <title>King Vision Channeled VL</title>
          <description>Group B: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group B (N= 75) were intubated utilizing the King Vision Channeled VL.</description>
        </group>
        <group group_id="B3">
          <title>King Vision Non-Channeled (Standard) VL</title>
          <description>Group C: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group C (N=75) were intubated utilizing the King Vision Video Laryngoscope with Standard (Non-Channeled) Blade.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
            <count group_id="B2" value="75"/>
            <count group_id="B3" value="75"/>
            <count group_id="B4" value="225"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="65"/>
                    <measurement group_id="B4" value="196"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.1" spread="11.8"/>
                    <measurement group_id="B2" value="48.0" spread="15.2"/>
                    <measurement group_id="B3" value="50.0" spread="14.2"/>
                    <measurement group_id="B4" value="48.7" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="40"/>
                    <measurement group_id="B4" value="120"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height (in)</title>
          <units>inches</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.7" spread="4.2"/>
                    <measurement group_id="B2" value="66.4" spread="4.3"/>
                    <measurement group_id="B3" value="66.4" spread="4.2"/>
                    <measurement group_id="B4" value="66.5" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight (kg)</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117.5" spread="20.3"/>
                    <measurement group_id="B2" value="116.2" spread="25.5"/>
                    <measurement group_id="B3" value="116.8" spread="21.5"/>
                    <measurement group_id="B4" value="116.8" spread="22.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (kg/m2)</title>
          <units>kilogram per meter square</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.2" spread="8.1"/>
                    <measurement group_id="B2" value="41.4" spread="9.9"/>
                    <measurement group_id="B3" value="41.1" spread="8.5"/>
                    <measurement group_id="B4" value="41.2" spread="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Neck Circumference (cm)</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.1" spread="4.3"/>
                    <measurement group_id="B2" value="47.1" spread="4.7"/>
                    <measurement group_id="B3" value="47.9" spread="4.3"/>
                    <measurement group_id="B4" value="47.3" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Interincisor distance (cm)</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.1" spread="1.0"/>
                    <measurement group_id="B2" value="4.1" spread="0.9"/>
                    <measurement group_id="B3" value="4.1" spread="1.0"/>
                    <measurement group_id="B4" value="4.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Thyromental distance (cm)</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.8" spread="1.7"/>
                    <measurement group_id="B2" value="6.8" spread="1.9"/>
                    <measurement group_id="B3" value="7.1" spread="1.7"/>
                    <measurement group_id="B4" value="6.9" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sternomental distance (cm)</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.4" spread="2.3"/>
                    <measurement group_id="B2" value="13.6" spread="2.3"/>
                    <measurement group_id="B3" value="13.7" spread="2.1"/>
                    <measurement group_id="B4" value="13.5" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Overall Successful Tracheal Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL</title>
        <description>The overall intubation success rates for all 3 video laryngoscopes - GSAVL, KVChVL and KVNChVL</description>
        <time_frame>During laryngoscopy and endotracheal tube placement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Glidescope AVL</title>
            <description>Group A: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group A (N= 75) were intubated utilizing the GlideScope® AVL.</description>
          </group>
          <group group_id="O2">
            <title>King Vision Channeled VL</title>
            <description>Group B: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group B (N= 75) were intubated utilizing the King Vision Channeled VL.</description>
          </group>
          <group group_id="O3">
            <title>King Vision Non-Channeled (Standard) VL</title>
            <description>Group C: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group C (N=75) were intubated utilizing the King Vision Video Laryngoscope with Standard (Non-Channeled) Blade.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Successful Tracheal Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL</title>
          <description>The overall intubation success rates for all 3 video laryngoscopes - GSAVL, KVChVL and KVNChVL</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="61"/>
                    <measurement group_id="O3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First-attempt Successful Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL</title>
        <description>The overall first-attempt success rates for all 3 video laryngoscopes - GSAVL, KVChVL and KVNChVL</description>
        <time_frame>During laryngoscopy and endotracheal tube placement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Glidescope AVL</title>
            <description>Group A: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group A (N= 75) were intubated utilizing the GlideScope® AVL.</description>
          </group>
          <group group_id="O2">
            <title>King Vision Channeled VL</title>
            <description>Group B: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group B (N= 75) were intubated utilizing the King Vision Channeled VL.</description>
          </group>
          <group group_id="O3">
            <title>King Vision Non-Channeled (Standard) VL</title>
            <description>Group C: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group C (N=75) were intubated utilizing the King Vision Video Laryngoscope with Standard (Non-Channeled) Blade.</description>
          </group>
        </group_list>
        <measure>
          <title>First-attempt Successful Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL</title>
          <description>The overall first-attempt success rates for all 3 video laryngoscopes - GSAVL, KVChVL and KVNChVL</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Final Intubation Time for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL</title>
        <description>Total time for placing the endotracheal tube (ETT) through the vocal cords</description>
        <time_frame>During laryngoscopy and endotracheal tube placement</time_frame>
        <population>Group A: 3 participants excluded due to protocol deviations. Group B: 8 participants excluded due to protocol deviations, 2 participant had failed intubation, 4 participants had device failure.
Group C: 2 participants excluded due to protocol deviations, 1 participant had device failure.</population>
        <group_list>
          <group group_id="O1">
            <title>Glidescope AVL</title>
            <description>Group A: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group A (N= 75) were intubated utilizing the GlideScope® AVL.</description>
          </group>
          <group group_id="O2">
            <title>King Vision Channeled VL</title>
            <description>Group B: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group B (N= 75) were intubated utilizing the King Vision Channeled VL.</description>
          </group>
          <group group_id="O3">
            <title>King Vision Non-Channeled (Standard) VL</title>
            <description>Group C: Patients were randomized into one of the three groups through a computer-generated randomization schedule. Patients in group C (N=75) were intubated utilizing the King Vision Video Laryngoscope with Standard (Non-Channeled) Blade.</description>
          </group>
        </group_list>
        <measure>
          <title>Final Intubation Time for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL</title>
          <description>Total time for placing the endotracheal tube (ETT) through the vocal cords</description>
          <population>Group A: 3 participants excluded due to protocol deviations. Group B: 8 participants excluded due to protocol deviations, 2 participant had failed intubation, 4 participants had device failure.
Group C: 2 participants excluded due to protocol deviations, 1 participant had device failure.</population>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="72"/>
                <count group_id="O2" value="61"/>
                <count group_id="O3" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.1" spread="27.4"/>
                    <measurement group_id="O2" value="44.9" spread="21.5"/>
                    <measurement group_id="O3" value="47.0" spread="24.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Postoperatively in the PACU</time_frame>
      <desc>(Other Adverse Events) Group A: 3 participants excluded due to protocol deviations, 8 participants lost to follow up.
Group B: 8 participants excluded due to protocol deviations, 2 participant lost to follow up.
Group C: 2 participants excluded due to protocol deviations, 3 participant lost to follow up.</desc>
      <group_list>
        <group group_id="E1">
          <title>Glidescope AVL</title>
          <description>Video laryngoscopes: Patients were randomized into one of the three groups through a computer generated randomization schedule. Patients in group A (N= 75) will be intubated using the GlideScope® AVL, patients in group B (N= 75) will be intubated using the King Vision Channeled VL; patients in group C (N=75) will be intubated using the King Vision Video Laryngoscope with Standard (non-channeled) Blade. Patients will only be tested with one device. All patients will be intubated using a conventional ETT.</description>
        </group>
        <group group_id="E2">
          <title>King Vision Channeled VL</title>
          <description>Video laryngoscopes: Patients were randomized into one of the three groups through a computer generated randomization schedule. Patients in group A (N= 75) will be intubated using the GlideScope® AVL, patients in group B (N= 75) will be intubated using the King Vision Channeled VL; patients in group C (N=75) will be intubated using the King Vision Video Laryngoscope with Standard (non-channeled) Blade. Patients will only be tested with one device. All patients will be intubated using a conventional ETT.</description>
        </group>
        <group group_id="E3">
          <title>King Vision Non-Channeled (Standard) VL</title>
          <description>Video laryngoscopes: Patients were randomized into one of the three groups through a computer generated randomization schedule. Patients in group A (N= 75) will be intubated using the GlideScope® AVL, patients in group B (N= 75) will be intubated using the King Vision Channeled VL; patients in group C (N=75) will be intubated using the King Vision Video Laryngoscope with Standard (non-channeled) Blade. Patients will only be tested with one device. All patients will be intubated using a conventional ETT.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Hoarseness</sub_title>
                <description>Hoarseness in voice postoperatively</description>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="70"/>
              </event>
              <event>
                <sub_title>Sore Mouth</sub_title>
                <description>Sore Mouth postoperatively</description>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="70"/>
              </event>
              <event>
                <sub_title>Sore neck</sub_title>
                <description>Sore neck postoperatively</description>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="70"/>
              </event>
              <event>
                <sub_title>Sore jaw</sub_title>
                <description>Sore jaw postoperatively</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="70"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <description>Dysphonia postoperatively</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="70"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <description>Dysphagia postoperatively</description>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="70"/>
              </event>
              <event>
                <sub_title>Alteration of tongue</sub_title>
                <description>Alteration of tongue postoperatively</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Elizabeth M. Gendel</name_or_title>
      <organization>The University of Texas Health Science Center at Houston (UTHealth)</organization>
      <phone>+1 (713) 500-3587</phone>
      <email>Elizabeth.M.Gendel@uth.tmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

